Treprostinil
Back to searchMolecule Structure
Scientific Name
Treprostinil
Description of the Drug
Treprostinil is a prostacyclin vasodilator for the treatment of pulmonary arterial hypertension to relieve exercise associated symptoms and to prevent clinical deterioration after stopping epoprostenol.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00374
http://www.drugbank.ca/drugs/DB00374
Brand Name(s)
Remodulin, Tyvaso, Tyvaso dpi
Company Owner(s)
United Therapeutics Corp, Alembic Global Holding Sa, Sandoz Inc, Par Sterile Products Llc, Dr Reddys Laboratories Ltd, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Prostanoid IP receptor | SINGLE PROTEIN | AGONIST | CHEMBL1995 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4349618 | ||||
| Human Metabolome Database | HMDB0014518 | ||||
| DrugBank | DB00374 | ||||
| PubChem: Thomson Pharma | 14854155 | 14878554 | |||
| PubChem | 6918140 | ||||
| LINCS | LSM-45331 | ||||
| Nikkaji | J430.982K | ||||
| DrugCentral | 2720 | ||||
| Metabolights | MTBLC50861 | ||||
| ChemicalBook | CB32460050 | ||||
| Guide to Pharmacology | 5820 | ||||
| rxnorm | TREPROSTINIL | TYVASO | TREPROSTINIL DIOLAMINE | REMODULIN | ORENITRAM |
| ChEBI | 50861 | ||||
| ZINC | ZINC000003800475 |
